abstract |
The present invention provides inhibitors of O-GlcNAc transferase. Typically, the inhibitor is quinolinone-6-sulfonamide. The present invention also provides pharmaceutical compositions thereof and methods of using it in diabetes and its complications, neurodegenerative diseases, cancer, autoimmune diseases and inflammatory diseases. |